コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 Darapladib is a selective oral inhibitor of lipoprotein-associated phospholipase A2.
2 protein particles and is also referred to as lipoprotein-associated phospholipase A2.
3 idase (156+/-19 versus 89+/-8 ng/mL), higher lipoprotein-associated phospholipase A2 (242+/-12 versus
4 vs 0.30 mmol/L, 0.04 to 0.55, p<0.0001) and lipoprotein-associated phospholipase A2 (-52.2 ng/mL, 95
6 verall, women had higher levels of hsCRP and lipoprotein-associated phospholipase A2 after AMI compar
8 Plasma N-terminal-proANP, myeloperoxidase, lipoprotein-associated phospholipase A2, and oxidized lo
10 inhibitors of secretory phospholipase A2 and lipoprotein-associated phospholipase A2 are potential ca
11 ed with absent enzymatic activity of soluble lipoprotein-associated phospholipase A2; at CYP2F1, with
13 nogen, factor VII, apolipoproteins AI and B, lipoprotein-associated phospholipase A2, homocysteine or
16 rrant additional investigation of this novel lipoprotein-associated phospholipase A2 inhibitory mecha
20 h-sensitivity C-reactive protein (hsCRP) and lipoprotein-associated phospholipase A2 (Lp-PLA(2)).
24 e has been controversy regarding the role of lipoprotein-associated phospholipase A2 (Lp-PLA2) in ath
25 sought to document the presence and role of lipoprotein-associated phospholipase A2 (Lp-PLA2) in cal
26 The use of statins, PPARgamma agonists or lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibi
34 ata from over 50 000 patients that increased lipoprotein-associated phospholipase A2 (Lp-PLA2) mass o
36 ues regarding the precise role that secreted lipoprotein-associated phospholipase A2 (Lp-PLA2), also
37 (8, 12-iso-iPF(2 alpha)-VI isoform), plasma lipoprotein-associated phospholipase A2 (Lp-PLA2), Merco
38 protein [hsCRP]), and vascular inflammation (lipoprotein-associated phospholipase A2 [Lp-PLA2]) were
40 ensity lipoprotein cholesterol, adiponectin, lipoprotein-associated phospholipase A2 mass and activit
41 apolipoprotein B and A-I, lipoprotein(a), or lipoprotein-associated phospholipase A2 mass to risk sco
42 d reclassify 1.1%; lipoprotein(a), 4.1%; and lipoprotein-associated phospholipase A2 mass, 2.7% of pe
44 l clinical utility of lipoprotein-associated lipoprotein-associated phospholipase A2, myeloperoxidase
45 ere significantly associated with changes in lipoprotein-associated phospholipase A2 (n = 10; r = 0.6
46 tor-2 (P<0.001), interleukin-6 (P=0.04), and lipoprotein-associated phospholipase A2 (P=0.002), but n
48 atelet-activating factor acetylhydrolase, or lipoprotein-associated phospholipase A2, plays a proathe
49 h-sensitivity C-reactive protein (hsCRP) and lipoprotein-associated phospholipase A2 were measured 1
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。